CCL2 and colitis: Although direct regulation of epithelial cells by miR-124 in UC remains unconfirmed (81, 82), preclinical DSS-induced colitis models demonstrated dose-dependent anti-inflammatory effects of ABX464 (83), primarily through miR-124 mediated downregulation of CCL2.